Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Solid Volumes Fuel Church & Dwight (CHD) Q1 Earnings & Sales

Published 05/02/2018, 09:31 PM
Updated 07/09/2023, 06:31 AM

Church & Dwight Company, Inc. (NYSE:CHD) posted first-quarter 2018 results, wherein both top and bottom lines grew year over year and surpassed the Zacks Consensus Estimate. This marked the company’s sixth and third consecutive quarter of positive earnings and sales surprise, respectively.

Church & Dwight Co., Inc. Price, Consensus and EPS Surprise


Church & Dwight Co., Inc. Price, Consensus and EPS Surprise | Church & Dwight Co., Inc. Quote

Quarterly earnings of 63 cents per share surged 21.2% from adjusted earnings of 52 cents reported in the first quarter of 2017. Also, the bottom line topped the Zacks Consensus Estimate of 61 cents.

Quarter in Detail

The company reported sales of $1,006.0 million that advanced 14.7% year over year and exceeded the Zacks Consensus Estimate of $979 million.

Organic sales rose 3.8%, which beat the company’s guidance of 2%. The upside was backed by a 4.2% rise in global consumer products growth. This in turn was fueled by higher volumes (up 4.7%), somewhat negated by unfavorable product mix and pricing.

Adjusted gross margin contracted 80 basis points (bps) to 44.9% due to increased commodity and transportation expenses. Further, marketing costs (as a percentage of sales) escalated 20 bps to 10.5%, excluding buyouts. SG&A costs also rose 30 bps as a percentage of sales to 13.1%, mainly due to buyouts.

Segment Details

Consumer Domestic: Segment net sales were up 13.9% to $751.4 million, courtesy of gains from acquisitions and higher household and personal care sales. Organic sales improved 3.6% benefiting from a 5.3% increase in volume, partly negated by a 1.7% negative impact from price and product mix.

ARM & HAMMER liquid and unit dose laundry detergent, ARM & HAMMER cat litter, OXICLEAN stain fighters, BATISTE dry shampoo, VITAFUSION and L’IL CRITTERS gummy vitamins and TOPPIK and VIVISCAL hair care businesses continued to be the main growth drivers.

Consumer International: Segment net sales soared 26.3% to $180.7 million backed by recent acquisitions, broad-based sales growth for household and personal care products and improvements in export business. Organic sales jumped 6.8% driven by improved volumes (up 1.6%), along with better price and product mix (up 5.2%).

OXICLEAN in the export business; STERIMAR, ARM & HAMMER toothpaste and OXICLEAN in Mexico; and FEMFRESH and BATISTE in Australia provided an impetus to organic sales.

Specialty Products: Sales at this segment dipped 0.7% to $73.9 million. Organic sales slipped 1%, on account of a 3.8% drop in volumes, somewhat cushioned by favorable commodity pass-through pricing (up 2.8%), mainly in the animal productivity business. Management stated that reduced milk prices has been leading to soft demand in the dairy industry. On the contrary, poultry industry demand is on the rise, which has reduced the company’s focus on the dairy industry.

Other Financial Updates

Church & Dwight ended the quarter with cash and cash equivalents of $119.8 million, long-term debt of $1,802.1 million and total shareholders’ equity of $2,143.3 million.

In the first quarter, the company generated cash flow from operations of $155.5 million and incurred capital expenditure of $9.9 million.

The company recently announced a quarterly dividend of 21.75 cents per share, which is payable on Jun 1, 2018 to shareholders of record as on May 15.

Guidance for 2018

Innovations have been a key driver for Church & Dwight. As part of its long-term strategy to boost top and bottom lines, the company announced several new product launches in various categories. Though increased commodity and transportation costs are likely to weigh on gross margin in 2018, management expects solid volume growth and improved market share to offset these hurdles.

The company now expects 2018 reported sales to grow about 9%, in comparison to 8% expected earlier. Organic sales are still anticipated to rise 3% in 2018.

The company reiterated 2018 bottom-line view. Earnings per share is still envisioned in a range of $2.24-$2.28, reflecting adjusted earnings per share growth of 16-18%. However, earnings per share is expected to decline 21-23% on a reported basis.

Q2 Outlook

For the second quarter of 2018, the company expects reported and organic sales growth of 12% and 3%, respectively. It anticipates adjusted earnings per share of 46 cents in the quarter, reflecting year-over-year growth of 12% on an adjusted basis and 59% jump on a reported basis.

Church & Dwight carries a Zacks Rank #3 (Hold). The stock has gained 6.8% in the last six months, versus the industry’s drop of 7.7%.

Looking for More Promising Bets? Check These

Boston Beer (NYSE:SAM) with a long-term earnings per share growth rate of 9.5%, sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

United Natural Foods (NASDAQ:UNFI) with a long-term earnings per share growth rate of 8.2%, flaunts a Zacks Rank #1.

MEDIFAST INC (NYSE:MED) , with the same Zacks Rank as Boston Beer, has delivered back-to-back positive earnings surprises in the past two quarters.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


The Boston Beer Company, Inc. (SAM): Free Stock Analysis Report

United Natural Foods, Inc. (UNFI): Free Stock Analysis Report

MEDIFAST INC (MED): Free Stock Analysis Report

Church & Dwight Co., Inc. (CHD): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.